Abbott Laboratories  

(Public, NYSE:ABT)   Watch this stock  
Find more results for ABT
54.63
-0.02 (-0.04%)
After Hours: 54.63 0.00 (0.00%)
Oct 16, 4:31PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 54.52 - 54.91
52 week 37.38 - 55.43
Open 54.62
Vol / Avg. 3.73M/5.95M
Mkt cap 94.92B
P/E 83.88
Div/yield 0.26/1.94
EPS 0.65
Shares 1.74B
Beta 1.55
Inst. own 74%
Oct 18, 2017
Q3 2017 Abbott Laboratories Earnings Release - 9:30AM EDT - Add to calendar
Oct 18, 2017
Q3 2017 Abbott Laboratories Earnings Call - 9:00AM EDT - Add to calendar
Jul 20, 2017
Q2 2017 Abbott Laboratories Earnings Release
Jul 20, 2017
Q2 2017 Abbott Laboratories Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin 4.07% 5.10%
Operating margin 6.43% 15.27%
EBITD margin - 21.92%
Return on average assets 1.52% 2.26%
Return on average equity 3.44% 5.09%
Employees 75,000 -
CDP Score - A-

Address

100 Abbott Park Rd
ABBOTT PARK, IL 60064-3500
United States - Map
+1-847-9376100 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.

Officers and directors

Miles D. White Chairman of the Board, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brian B. Yoor Chief Financial Officer, Senior Vice President - Finance
Age: 47
Bio & Compensation  - Reuters
Michael T. Rousseau President - Cardiovascular and Neuromodulation
Age: 61
Bio & Compensation  - Reuters
Hubert L. Allen Executive Vice President, General Counsel, Secretary
Age: 51
Bio & Compensation  - Reuters
Stephen R. Fussell Executive Vice President - Human Resources
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brian J. Blaser Executive Vice President - Diagnostics Products
Age: 52
Bio & Compensation  - Reuters
John M. Capek Ph.D. Executive Vice President - Ventures
Age: 55
Bio & Compensation  - Reuters
Robert B. Ford Executive Vice President - Medical Devices
Age: 43
Bio & Compensation  - Reuters
Heather L. Mason Executive Vice President - Nutritional Products
Age: 56
Bio & Compensation  - Reuters
Roger M Bird Senior Vice President - U.S. Nutrition
Age: 60
Bio & Compensation  - Reuters